Filing Details
- Accession Number:
- 0001645627-17-000053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-05 11:41:04
- Reporting Period:
- 2017-05-03
- Filing Date:
- 2017-05-05
- Accepted Time:
- 2017-05-05 11:41:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Transaction Summary
| Purchased: | 30,000 shares | Avg. Price: $0.08 | Total Value: $2,364.90 |
| Number of Shares After Transactions: | 20,608,949 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,579,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,580,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,581,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,582,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,583,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,584,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,585,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,586,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,587,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,588,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,589,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,590,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,591,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,592,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,593,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,594,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,595,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,596,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,597,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,598,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,599,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,600,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,601,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,602,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,603,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,604,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,605,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,606,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,607,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,608,949 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
